EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions

Randy Yoo, Matthijs M Jore, Jean-Philippe Julien iD

Immunological Reviews · 2025

DOI: 10.1111/imr.70001 ↗

At a glance

Übersichtsarbeit in Immunological Reviews, 2025. Written by Randy Yoo and 2 co-authors. Institution: Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada. Major MEDLINE topics: Malaria Vaccines, Antibodies, Protozoan, Epitopes, Malaria. Cited 8 times so far (Crossref); 251 references. The full text is freely available (open access, CC BY 4.0). Funded by: Gates Foundation, CIHR, Open Philanthropy Project.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Malaria continues to pose a significant burden to global health. Thus, a strong need exists for the development of a diverse panel of intervention strategies and modalities to combat malaria and achieve elimination and eradication goals. Deploying interventions that target bottlenecks in the transmission life cycle of the causative agent of malaria, Plasmodium parasites, is an attractive strategy. The development of highly potent antibody‐based biologics, including vaccines, can be greatly facilitated by an in‐depth molecular understanding of antibody‐epitope interactions. Here, we provide an overview of structurally characterized antibodies targeting lead vaccine candidates expressed during the bottlenecks of the Plasmodium life cycle which include the pre‐erythrocytic and sexual stages. The repeat region of the circumsporozoite protein (CSP), domain 1 of Pfs230 and domains 1 and 3 of Pfs48/45 are critical Plasmodium regions targeted by the most potent antibodies at the two bottlenecks of transmission, with other promising targets emerging and requiring further characterization.

Subjects

MeSH terms (MEDLINE)

Malaria VaccinesAntibodies, ProtozoanEpitopesMalariaPlasmodiumPlasmodium falciparumHumansAnimalsProtozoan ProteinsAntigens, Protozoan

Author keywords

antibodymalariavaccines

Substances

Malaria VaccinesAntibodies, ProtozoanEpitopesProtozoan ProteinsAntigens, Protozoan

Authors and institutions

  • Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.
  • Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

ORCID profiles: Jean-Philippe Julien

Funding

  • Gates Foundation
  • CIHR
  • Open Philanthropy Project
  • Bill and Melinda Gates Foundation
  • NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • Canadian Institutes of Health Research

Cite

APA

Yoo, R., Jore, M. M., & Julien, J. P. (2025). Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions. Immunological Reviews. https://doi.org/10.1111/imr.70001

Vancouver

Yoo R, Jore MM, Julien JP. Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions. Immunological Reviews. 2025. doi:10.1111/imr.70001

BibTeX
@article{Yoo2025,
  author = {Yoo, Randy and Jore, Matthijs M and Julien, Jean-Philippe},
  title = {Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions},
  journal = {Immunological Reviews},
  year = {2025},
  doi = {10.1111/imr.70001}
}
Start for free →